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ABSTRACT 
 
The family of aminoacyl-tRNA synthetases (aaRSs) ensures the fidelity of translation 
through providing a pool of correctly aminoacylated tRNA products that become 
incorporated by the ribosome. Leucyl-tRNA synthetase (LeuRS) has two functionally 
separate domains, one is the aminoacylation domain and the other is the CP1 editing domain. 
LeuRS can aminoacylate noncognate amino acids, therefore it relies on the CP1 editing 
domain to hydrolyze misaminoacylated tRNA products before they are released from the 
enzyme. The LeuRS enzyme must undergo a structural transition state in its reaction cycle in 
order to translocate the 3’ acceptor stem of tRNA 30 Å from the aminoacylation active site to 
the CP1 domain hydrolytic active site. The translocation event is difficult to study, but we 
believe that we have generated mutations within LeuRS that alter the translocation event of 
tRNA. The mutations that we have generated lead to bacterial death in Escherichia coli (E. 
coli). Circular dichorism experiments indicate that our mutations do not significantly alter the 
secondary structure of LeuRS. In vitro biochemical studies demonstrate that these mutations 
reduce the rates of aminoacylation and hydrolysis, while also displaying misaminoacylation 
activity. We attribute these biochemical findings to the resulting bacterial death that is caused 
by these mutations. 
 
Introduction 
 
Polymerization of amino acids during canonical protein translation is an accurate process 
with a misincorporation rate of 1 per 2000 amino acids (Drummond & Wilke, 2008). During 
translation, cells employ many quality control mechanisms that maintain the precise 
production of proteins. The first quality control step is maintained by aminoacyl-tRNA 
synthetases (aaRSs) through the synthesis of aminoacylated tRNAs. All aaRSs rapidly bind 
their cognate amino acid and tRNA to turn-over an accurately aminoacylated tRNA product 
(Hendrickson & Schimmel, 2003). To ensure the fidelity of aminoacylation many aaRSs rely 
on a two-active site system termed “the double sieve model” for editing mistakes (Fersht, 
1998; Fersht & Dingwall, 1979). Aminoacylation takes place in the synthetic active site 
termed “the coarse sieve,” which can exclude structurally dis-similar substrates. The second 
sieve is termed “the fine sieve,” and acts through a hydrolysis reaction to cleave incorrectly 
aminoacylated homologous products. When the editing process has been rendered defunct 
through mutational analysis, the results have been found to be deleterious for both 
prokaryotic and eukaryotic cells (Karkhanis, Boniecki, Poruri, & Martinis, 2006; Lee et al., 
2006; Nangle, Zhang, Xie, Yang, & Schimmel, 2007) 
 
The family of aaRSs are divided into two classes that are believed to have co-evolutionary 
pathways that have functionally merged from two different primitive biological 
processes(Woese, Olsen, Ibba, & Soll, 2000). Class I and class II aaRSs are distinct in both 
their structural features and their respective mechanisms of aminoacylation(Ibba & Soll, 
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2000; Woese et al., 2000). These structural features are known as protein folding motifs, 
which commonly occur in nature. Once such structural motif is the Rossmann fold, which is 
known to bind to nucleotides and nucleotide derivatives such as nicotinamide adenine 
dinucleotide (NAD)(Rao & Rossmann, 1973). Class I aaRSs employ the Rossmann fold to 
house the aminoacylation active site, which structurally consists of parallel - strands with 
the signature amino acid sequences KMSKS and HIGH (Rould, Perona, Soll, & Steitz, 1989; 
Schmitt, Meinnel, Blanquet, & Mechulam, 1994; Webster, Tsai, Kula, Mackie, & Schimmel, 
1984). The active site within the Rossmann fold binds to ATP, the cognate amino acid and 
tRNA to carry out the two-step aminoacylation reaction (as can be seen below in the reaction 
schematic) (Arnez & Moras, 1997). For some class I aaRSs there is a second active site, 
which is housed within a separate domain. To generate this second domain, the Rossmann 
fold is split by a connective polypeptide domain (CP1) insertion sequence (Cusack, 
Yaremchuk, & Tukalo, 2000). The CP1 domain is only present in 4 of the 11 class I aaRSs. 
The CP1 domain houses the editing active site, which structurally excludes correctly 
aminoacylated products while hydrolyzing misaminoacylated amino acids from the tRNA 
(Mursinna, Lincecum, & Martinis, 2001; Swairjo & Schimmel, 2005). These two actives sites 
work in conjunction to ensure that a pool of viable aminoacylated tRNAs are ready for 
ribosomal incorporation during protein translation, thereby reducing the misincorporation rate 
(Hendrickson & Schimmel, 2003). 
 
 
 
Optimal coordination of the two active sites requires communication. The charged tRNA 
product initially within the aminoacylation active site, chemically communicates with the 
CP1 domain as it translocates into the editing hydrolytic active site (Hellmann & Martinis, 
2009). In addition, there is structural communication that requires the CP1 domain to toggle 
in relation to the aminoacylation active site via flexible linker sequences that act as a 
molecular hinge (Mascarenhas & Martinis, 2008). These processes have been studied 
extensively for the class I aaRSs that have the CP1 domain insert such as: leucyl-tRNA 
synthetase (LeuRS) and the homologous isoleucyl-tRNA synthetase (IleRS) and valyl-tRNA 
synthetases (ValRS) (Starzyk, Burbaum, & Schimmel, 1989). Interestingly, though the two 
domains have many modes of communication, the CP1 domain is known to fold 
independently of the aminoacylation domain (Cusack et al., 2000; Fukai et al., 2000; Silvian, 
Wang, & Steitz, 1999). In addition, when the aminoacylation and CP1 domains have been 
expressed as separate independent enzymes, they can still carry out their respective reactions 
(Betha, Williams, & Martinis, 2007; Boniecki & Martinis, 2012; Lin, Hale, & Schimmel, 
1996; Zhao et al., 2005). 
 
X-ray crystallography data has recently shown that E. coli LeuRS’s structure during the 
reaction cycle is highly dynamic (Palencia et al., 2012). Many of the domains undergo drastic 
structural and positional changes as the enzyme initiates aminoacylation followed by the 
hydrolytic reaction (Palencia et al., 2012). These structural and positional changes help 
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support the movement of tRNA between the aminoacylation and editing active sites, which 
are separated by about 30 Å (Palencia et al., 2012). It has been previously reported that the 3’ 
acceptor stem of the tRNA must be translocated between the two active sites during LeuRS’s 
reaction cycle (Lincecum et al., 2003; Mascarenhas & Martinis, 2008). Furthermore, the 
tRNA’s translocation is believed to be specifically supported by interactions with the CP1 
domain (Hellmann & Martinis, 2009; Mascarenhas & Martinis, 2008). 
 
We hypothesize that the tRNA 3’ acceptor stem has to first be translocated into the 
aminoacylation active site before the enzyme can begin its reaction cycle and that the CP1 
domain structurally supports this initial translocation event, as has been previously suggested 
(Rock et al., 2007). Two computationally predicted hinge sites have been identified in the 
CP1 domain, which suggests that this region of the enzyme is highly dynamic and therefore 
capable of supporting this type of movement (Hellmann & Martinis, 2009; Mascarenhas & 
Martinis, 2008). The two molecular hinge sites have been previously described as the -
strand linker sequences and the translocation peptide (Hellmann & Martinis, 2009; 
Mascarenhas & Martinis, 2008). Additional mutations (D391A and F382A/N383A (FN1)) 
have been identified in the translocation peptide that has rendered the LeuRS enzyme non-
functional in E. coli cells. Herein, we report our biochemical findings to support the claim 
that these additional sites within the translocation peptide may be integral in the pre-
aminoacylation and post-aminoacylation movements of tRNA into and out of aminoacylation 
active site. These mutations have been found to reduce the rates of aminoacylation, 
hydrolysis, and to have misaminoacylation activity. Due to the reduced chemical reaction 
rates, we believe that the mutations may play a role in stabilizing the tRNA as it translocates 
between the two active sites. 
 
Materials and Methods 
 
Materials 
 
T7 RNA polymerase (Invitrogen, Carlsbad, CA) was used to in vitro transcribe tRNALeu via 
run-off transcription (Sampson & Uhlenbeck, 1988). The in vitro transcription protocol is as 
follows: transcripts encoding the tRNALeu gene were obtained first by purifying 450 g/mL 
of ptDNAleu14 (Normanly, Ogden, Horvath, & Abelson, 1986) using an alkaline lysis 
protocol. The ptDNAleu14 was restricted digested with BstNI and incubated overnight at 60 
oC. Digested plasmid was confirmed by agarose gel electrophoresis. The product resulting 
from the BstNI digest was used as a template for in vitro transcription reactions containing 40 
mM Tris-HCl, pH 8.0, 30 mM MgCl2, 5 mM dithiothreitol (DTT), 0.01 % Triton X-100, 40 U 
RNase inhibitor (Eppendorf, Westbury, NY) 8 g/ml pyrophosphatase (Sigma, St. Louis, 
MO), 5 mM spermidine, 50 g/ml bovine serum albumin (BSA), 7.5 mM each of ATP, CTP, 
GTP, and UTP, 80 mg/ml polyethylene glycol (PEG) 8000, 60 g/ml DNA plasmid template 
and 17 M T7 RNA polymerase. The tRNA product was purified by urea-containing 
polyacrylamide gel electrophoresis (Sampson & Uhlenbeck, 1988) and quantitated based on 
absorbance at 260 nm using an extinction coefficient of 840,700 L/mol●cm (Puglisi & 
Tinoco, 1989). Purified tRNALeu was denatured at 80o C for 1 min, followed by an addition of 
1 mM MgCl2 and quick-cooling on ice for re-folding. 
 
Methods 
 
Generating Mutations: The wild type E. coli LeuRS gene is encoded within the plasmid 
pRWecLeuRS, which was generated by extracting E. coli genomic DNA and utilizing PCR to 
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amplify and subsequently clone leuS (GeneBank Accession #EG10532) into pET15b (Fisher 
Scientific, Pittsburg, PA) as previously demonstrated by Härtlen, M. and Madern, D., 
1987(Hartlein & Madern, 1987). To generate pRWecLeuRS we used synthesized 
oligonucleotides (Integrated DNA Technology (IDT), Coralville, IA). The forward primer 5’-
CGCCATATGATGCAAGAGCAATACCGCCCG-3’ and reverse primer 5’-
CGCGGATCCCGGTTGCTGGTCTAACTCCTC-3’, which contain the NdeI and BamHI 
restriction sites, respectively. The resulting pRWecLeuRS was used to insert mutations via 
PCR generating the plasmids: pRWFN1 (F382A/N383A), and pRHD391A (D391A). These 
mutations were constructed using synthesized complementary oligonucleotides, the FN1 
mutation was generated with the forward primer 5’-
GACTGAAAAAGGCGTGCTGGCTGCATCTGGCGAGTTCAACG-3’ and the D391A 
mutation was generated with the forward primer 5’-
CGAGTTCAACGGTCTTGCCCATGAAGCGGCCTTCAACG-3’. In addition, we 
generated the T252Y mutant to purify the mischarged product [3H] Ile-tRNALeu (as described 
below) with the following forward primer: 5’-CCCGCCGGACTACTTTATGGGTTGTACC-
3’.(Mursinna & Martinis, 2002) DNA sequencing for all plasmids was carried out by 
Eurofins MWG Operon, Huntsville, AL. 
 
Protein Expression: To express the LeuRS mutants FN1 and D391A, the pRHFN1 and 
pRHD391A plasmids were used to transform E. coli BL21 (Stratagene, La Jolla, CA). A 
single colony was used to inoculate 5 ml of Luria-Bertani medium containing 100 g/ml 
ampicillin (LB-Amp) and grown overnight at 37 oC. The overnight culture was then 
transferred to 1 L of LB-Amp and grown at 37 oC to an OD600 of 0.6-0.8. Expression of 
LeuRS was induced with 1 mM IPTG for 3 hrs at 37 oC. Harvested cells were lysed by 
sonication and each LeuRS, which contained an N-terminal six-histidine tag, was purified by 
affinity purification using HIS-Select HF nickel affinity resin as described before 
(Mascarenhas & Martinis, 2008). The purified proteins were concentrated via Pierce 
concentrators 50K MWCO (Thermo Scientific, Rockford, IL) and quantitated using the Bio-
Rad protein assay according to the commercial protocol. 
 
Growth Curve Analysis: Growth curves for selected E. coli KL231 transformants that 
contained plasmids pRWFN1 and pRWD391A were grown in 3 ml of minimal standard (MS) 
medium (Low, Gates, Goldstein, & Soll, 1971). The MS-media was supplemented with 100 
µg/ml of each of the following amino acids: leucine, isoleucine, valine, arginine, histidine, 
lysine, methionine, phenylalanine, threonine, tryptophan, and tyrosine. It also included 40 
µg/ml uracil, 40 µg/ml adenine, 200 µg/ml thymine, 100 µg/ml thiamine, and 2% glucose. 
Antibiotics including kanamycin (30 µg/ml), streptomycin (50 µg/ml), and ampicillin (100 
µg/ml) were also added to generate MS-Amp/Kan/Str. Overnight cultures were transferred to 
50 ml of MS-Amp/Kan/Str medium for growth curve analysis, which was conducted at 42 °C. 
Aliquots of 1 mL were taken every 2 hr until 20 hr of incubation were completed. At 30 hr 
and 48 hr another set of aliquots were recovered. Aliquots of the cell cultures were analyzed 
by taking the OD600 using an ultraviolet-visible spectrophotometer (Thermo Scientific, 
Waltham, MA). 
 
Growth curves were also performed in E. coli BL21 cell (Stratagene, La Jolla, CA) 
transformants of pRWFN1 and pRWD391A. A single colony was used to inoculate 5 ml of 
LB-Amp and grown overnight at 37 oC. Overnight cultures were transferred to 50 ml of LB-
Amp for growth curve analysis, which was conducted at 37 °C. Aliquots of 1 mL were taken 
every 2 hr until 20 hr of incubation were completed. At 30 hr and 48 hr another set of aliquots 
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were recovered. Aliquots of the cell cultures were analyzed by taking the OD600 using an 
ultraviolet-visible spectrophotometer (Thermo Scientific, Waltham, MA). 
 
Aminoacylation Assays: Leucylation reactions contained 60 mM Tris-HCl, pH 7.5, 10 mM 
MgCl2, 1 mM DTT, 4 M folded tRNALeu, 21 M [3H]-L-leucine (150 Ci/ml) and 50 nM 
enzyme. Alternatively, isoleucylation reactions contained the same components, except 21 
M [3H]-L-isoleucine (radioactivity) was added instead of the tritiated leucine. Initial 
velocities for the leucylation reactions were obtained using 10 nM of enzyme. All reactions 
were initiated by the addition of 4 mM ATP and then quenched at specific time points by 
transfer to filter pads (Whatman, Clifton, NJ) that had been pre-soaked with 200 L of 5% 
trichloroacetic acid (TCA). The pads were then washed three times with cold 5% TCA, 
followed by one wash with cold 70% ethanol at 10 min time durations for each washing. The 
pads were dried by soaking in ethyl ether and then under an ultra-red lamp. Each pad was 
transferred into a 20 ml scintillation vial with 3 mL of scintillation fluid (Fisher Scintisafe 
EconoF) and quantitated using a HIDEX Triathler Liquid Scintillation Counter. 
 
Charged tRNA Preparation and Enyzmatic Deacylation: The [3H]-Leu-tRNAleu was 
generated in a one hour incubation of the leucylation reaction described above. The [3H]-Ile-
tRNAleu was prepared using an editing defective T252Y LeuRS mutant in an aminoacylation 
reaction that was incubated at 30 oC for 3 hr. Reactions were stopped using 0.18% acetic 
acid, and extracted using two equal volumes of phenol/chloroform/isoamyl alcohol, pH 4.3 
(125:24:1) (Schreier & Schimmel, 1972). A one-half volume of 4.6 M NH4OAc, pH 5.0, was 
added followed by an ethanol precipitation. The dried aminoacylated tRNA pellets were 
resuspended in 10 mM KH2PO4, pH 5.0. Hydrolytic editing assays were carried out at room 
temperature in 60 mM Tris, pH 7.5, 10 mM MgCl2, and 0.8 M [3H]-Leu-tRNALeu or 0.8 M 
[3H]-Ile-tRNAleu and was initiated with 100 nM enzyme (Mursinna et al., 2001). At specific 
time points, 5 l aliquots were spotted onto filter pads, washed, and quantitated. 
 
Structural Analysis of Wild type, FN1 and D391A mutants: Circular Dichorism was used to 
characterize the relative -helix and -sheet content of the wild type and mutant LeuRS 
enzymes. Each enzyme was diluted to 0.8 mg/mL in potassium phosphate buffer (10 mM 
KH2PO4 and 10 mM K2HPO4 pH 7.4). The enzymes were then inserted into a JASCO J-810 
circular dichroism spectropolarimeter set at 25 oC using 50 nm/min scan speed, 0.5 sec time 
constant and a 1 nm bandwidth (Kelly, Jess, & Price, 2005). 
 
Results 
 
Examination of the Structural Impact of the FN1 and D391A mutations 
 
The LeuRS mutations FN1 and D391A reside within the translocation peptide. The 
translocation peptide is approximately 12 Å away from bound tRNA (Hellmann & Martinis, 
2009). Based on x-ray crystallography images of LeuRS in the aminoacylation and editing 
conformations, the translocation peptide is projected to move ± 12-15o with the rotational 
movement of the CP1 domain (Figure 1A) (Palencia et al., 2012).  
 Bridges 9 (Spring 2015)  6 
 
 
Figure 1A 
Figure 1A. Secondary and Tertiary structure of the E. coli LeuRS and FN1 and D391A Mutants. E. coli LeuRS 
aminoacylation and editing X-ray crystal structures (Palencia et al., 2012). The CP1 domain (yellow) is inserted into the 
catalytic aminoacylation core (green) via two β-strand linkers. The mutants D391A and FN1 are depicted as ball and stick 
structures colored blue.  
 
Previously published results have shown that the residues H392 and E393 specifically 
interact with the tRNA molecule to promote its translocation between the two active sites of 
LeuRS. This claim was supported by biochemical and computational evidence (Hellmann & 
Martinis, 2009). The residues D391, H392 and E393 are all part of a computationally 
predicted hinge region that has been projected to be a very dynamic region of the CP1 
domain. As can be seen in figure 1A, the molecular hinge divides the translocation peptide 
into two halves, with both ends forming -helical structures. D391 sits in the center of 
translocation peptide. Being that D391 is at the center of the molecular hinge site, it may 
contribute to crucial conformational changes the translocation peptide may experience during 
the transient translocation step. In addition, because of the position of D391, this residue 
could form electrostatic interactions with the bound tRNA. The F382 and N383 residues are 
outside of the molecular hinge region, and are at the distal end of the translocation peptide in 
relation to tRNA (Figure 1A). Therefore, it would be unlikely that these residues have direct 
interactions with tRNA. However, based on the structures of LeuRS and the positions of 
F382 and N383, these residues most likely play vital secondary structural roles in helping to 
provide the correct orientation of the translocation peptide so that it may interact with the 
tRNA. F382 and N383 are proximal to other aromatic residues in the CP1 domain, which 
could allow for base-stacking interactions thus stabilizing the translocation peptide. 
 
As will be addressed, these two mutations have been characterized as non-functional in E. 
coli cells. To rule out the possibility that the bacterial death caused by these mutations result 
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from regional or global denaturation of the secondary structural features of LeuRS, we 
conducted circular dichorism analysis of the mutant enzymes in relation to the wild type 
enzyme (Figure 1B). As indicated by figure 1B, the circular dichorism spectrum indicates 
that the mutants have similar secondary structural features to the wild type enzyme. 
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Figure 1B 
Figure 1B. Secondary and Tertiary structure of the E. coli LeuRS and FN1 and D391A Mutants. Circular Dichorism 
spectrum of WT (wild type), (  ); FN1, (  ); and D391A, (  ). Sample concentration was 0.8 mg/mL in potassium phosphate 
buffer (10 mM KH2PO4 and 10 mM K2HPO4 pH 7.4). Each enzyme was scanned in triplicate using a JASCO J-810 circular 
dichroism spectropolarimeter set at 25 oC using 50 nm/min scan speed, 0.5 sec time constant and a 1 nm bandwidth (Kelly et 
al., 2005). 
 
Growth curve analysis indicates FN1 and D391A are non-functional in E. coli cells 
 
The pRWFN1 and pRWD391 plasmids were used to transform E. coli BL21 cells and were 
then grown in liquid LB-Amp media over a period of 48 hrs. The growth of the cells was 
monitored spectroscopically to determine their intracellular behavior. The FN1 and D391A 
mutants grew in a similar manner to the wild type enzyme (Figure 2A).  
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Figure 2A 
Figure 2A. Growth curve of wild type LeuRS, and the mutants FN1, and D391A, using E. coli BL21 strain and the 
temperature sensitive E. coli KL231 strain. Growth Curve of WT, FN1 and D391A in E. coli BL21. Cell growth was carried 
out at 37 oC. Symbols represent the following: WT (wild type), (■); FN1, (▲); and D391A, (◊). Error bars are present for all 
points and represent growth curves that were repeated in triplicate. 
 
Normal growth was observed because the genomic copy of wild type LeuRS was still active 
in the E. coli BL21 cells, thus rescuing growth. Interestingly, we observed a similar result 
when the pRWFN1 and pRWD391 plasmids were used to transform the temperature sensitive 
E. coli KL231 cells, which were grown at 30 oC. Again, this result is due to expression of 
genomic LeuRS within E. coli KL231 cells at 30 oC (Low et al., 1971). The non-functional 
behavior of these mutants became evident when the genomic copy of LeuRS was rendered 
functionally inactive within E. coli KL231 cells grown at 42 oC (Figure 2B) (Low et al., 
1971).  
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Figure 2B 
Figure 2B. Growth curve of wild type LeuRS, and the mutants FN1, and D391A, using E. coli BL21 strain and the 
temperature sensitive E. coli KL231 strain. Growth Curve of WT, FN1 and D391A in E. coli KL231. Cell growth was 
carried out at 42 oC. Symbols represent the following: WT (wild type), (■); FN1, (▲); and D391A, (◊). Error bars are 
present for all points and represent growth curves that were repeated in triplicate. 
 
 At this elevated temperature, both mutants were unable to complement E. coli KL231 as 
shown in Figure 2B and therefore failed to significantly support cellular growth. Therefore, 
from the growth curve analysis, we have shown that FN1 and D391A reduce the growth of E. 
coli cells by approximately 80% and that this finding indicates that these mutations are non-
functional. Thus, these mutations must significantly impact the biochemical behavior of 
bacterial LeuRS. 
 
Biochemical evidence supports the role of FN1 and D391A in tRNA movement 
 
In order to determine how these enzymes impact the biochemical behavior of LeuRS, the 
FN1 and D391A mutants were purified through ion-exchange chromatography as previously 
described in the Methods section. The purified enzymes were initially tested for their ability 
to leucylate tRNA (Figure 3A).  
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Figure 3A 
Figure 3A. Biochemical Analysis of WT, FN1 and D391A LeuRS Enzymes. Leucylation activity of wild type and mutant 
LeuRSs. The reaction was carried out with 50 nM LeuRS, 4 μM tRNALeu transcript, and 22 M [3H]-leucine (167 Ci/ml). 
Symbols represent: WT (wild type), (■); FN1, (▲); D391A, (◊); and No Enzyme (x). Error bars are present for all points and 
represent reactions that were repeated in triplicate.  
 
As indicated in figure 3A, these mutants have reduced leucylation activity when compared to 
the wild type enzyme. This finding correlates with the results of bacterial death by suggesting 
that the mutant enzymes cannot turn-over leucylated tRNA fast enough for ribosomal 
incorporation. This would then lead to leucine-deficient proteins and thereby increase the 
amount of aberrant proteins being produced in the cell, thus cellular death. 
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Additionally, it can be seen in figure 3A that both FN1 and D391A fail to reach a maximal 
reaction velocity, which is represented by the plateau of leucylation activity (as seen in the 
wild type results). This plateau value represents an equilibrium between the acylation event 
and the deacylation events (Bonnet & Ebel, 1972). The deacylation events can occur through 
spontaneous hydrolysis of the ester linkage between the amino acid and tRNA or through 
enzyme-mediated deacylation, which also results in the hydrolysis of the acylated product 
(Bonnet & Ebel, 1972). For the wild-type enzyme these processes are in near exact 
equilibrium, but for FN1 and D391A equilibrium is never reached (figure 3A). The results 
indicate that the mutant enzymes may reduce the rates of translocation and therefore fail to 
produce enough acylated product to be in equilibrium with the deacylated products. 
Based on our data, FN1 and D391A seem to influence the translocation of the 3’ acceptor 
stem of tRNA into the leucylation active site and then into the CP1 editing active site. We 
preformed deacylation assays with the misacylated substrate Ile-tRNALeu as previously 
described. In relation to wild type LeuRS, FN1 and D391A had very slow deacylation 
activity and failed to reach an equilibrium state (Figure 3B).  
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Figure 3B 
Figure 3B. Biochemical Analysis of WT, FN1 and D391A LeuRS Enzymes. Deacylation of mischarged E. coli Ile-tRNALeu 
by wild type and mutant LeuRSs. Reaction conditions include 1.5 µM [3H]-Ile-tRNALeu and 5 nM enzyme. Symbols 
represent: WT (wild type), (■); FN1, (▲); D391A, (◊); and No Enzyme (x). Error bars are present for all points and 
represent reactions that were repeated in triplicate.  
 
FN1 and D391A deacylated approximately 50% of the available Ile-tRNALeu substrate. In 
general, deacylation activity is represented by three events that cannot be separated in this 
assay. First, there is spontaneous deacylation occurring in solution (Bonnet & Ebel, 1972). 
Second, there is enzymatic deacylation which involves the translocation of tRNA into the 
editing active site (Hellmann & Martinis, 2009). Third, is the deacylation of tRNA when it 
binds directly in the editing active site without undergoing a translocation event (Betha et al., 
2007). Therefore, from our data it appears that FN1 and D391A both have significantly 
reduced translocation activity of the 3’ acceptor stem of the tRNA into the editing active site. 
 
Lastly, we conducted a misaminoacylation biochemical assay to assess whether FN1 and 
D391A would allow for the misaminoacylation of tRNA in the presence of noncognate amino 
acid. We have likened the aminoacylation active site to a “coarse sieve” whereby all 
structurally homologous amino acids would be charged to the 3’ acceptor stem of tRNA. The 
FN1 and D391A mutants are believed to inhibit efficient tRNA translocation between the 
active sites. Figure 3C indicates that FN1 and D391A have misaminoacylation activity in the 
presence of noncognate amino acid. From the graph, FN1 and D391A have 2.5-5 times 
higher misaminoacylation activity than the wild type enzyme. These mischarging activities 
are directly correlated to a defunct translocation pathway resulting from these two mutations. 
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Figure 3C 
Figure 3C. Biochemical Analysis of WT, FN1 and D391A LeuRS Enzymes. Misaminoacylation activity of wild type and 
mutant enzymes. Isoleucine mischarging reactions were carried out with 1 M LeuRS enzyme, 4 μM tRNALeu transcript, and 
22 M [3H]-isoleucine (167 Ci/ml). Symbols represent: WT (wild type), (■); FN1, (▲); D391A, (◊); and No Enzyme (x). 
Error bars are present for all points and represent reactions that were repeated in triplicate.  
 
Discussion and Conclusions 
 
From the structural and biochemical data we have gathered, FN1 and D391A do not appear to 
significantly impact the structural or functional characteristics of either active site of LeuRS. 
Structural data obtained through circular dichorism suggests that these mutants do not 
significantly alter the regional or global structure of LeuRS when compared to the spectra of 
the wild type enzyme. Furthermore, based on recently published x-ray crystallography data 
(Palencia et al., 2012), we believe these sites of mutations are too far removed from either 
active to significantly impact their functionality. Since we can rule out the possibility that 
these mutants structurally alter LeuRS, we believe that these mutants influence the 
biochemistry of LeuRS by altering the chemical communication between the active sites. 
 
We hypothesize that FN1 and D391A affect the chemical communication between the two 
active sites by inhibiting efficient movement of the tRNA. Based on our findings, we have 
demonstrated that both of these mutations reduce the rate of leucylation as well skew the 
equilibrium of product formation. It has been previously reported that the leucylation reaction 
is a two-step reaction which can be broken down into a synthesis step followed by a product-
release step (Francklyn, First, Perona, & Hou, 2008; Hellmann & Martinis, 2009). Mutations 
made within the translocation peptide were reported to alter the rate of the product-release 
step (Hellmann & Martinis, 2009). By extension, we hypothesize that D391A (which is 
within the molecular hinge region) and FN1 alter the rate of leucylation as was demonstrated 
in figure 3A, by reducing the efficiency of the tRNA translocation.  
 
Based on the biochemical evidence presented in figure 3A, we hypothesize that the reduction 
in leucylation activity is two-fold. First, the initial rates of leucylation for the mutant enzymes 
are reduced by 50% or more. It has been previously proposed that tRNA translocation 
consists of the initial movement of the tRNA 3’ acceptor stem into the leucylation active site 
and then a second translocation event which places the 3’ acceptor stem in the hydrolytic 
active site (Hellmann & Martinis, 2009; Rock et al., 2007). If FN1 and D391A play a 
structurally supportive role in the translocation peptide’s interaction with tRNA, then the 
initial rates of leucylation would naturally be reduced as the CP1 domain is less effective at 
initiating the movement of tRNA into the leucylation active site. Thus, this biochemical data 
suggests that FN1 and D391A both may cause the early release of tRNA before it is 
translocated to the CP1 domain for editing. The early release of the tRNA may happen before 
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the tRNA is charged with amino acid during the initial translocation into the aminoacylation 
active site.  
 
As a result of this hypothesis, we propose that these mutants may initiate a leaky futile 
reaction cycle. The futile reaction cycle may consist of the following steps: 1. LeuRS binds 
tRNA, 2. enzyme fails to rapidly aminoacylate the tRNA, 3. LeuRS pre-maturely releases the 
tRNA, 4. the tRNA re-binds to the enzyme. This futile reaction mechanism would 
significantly reduce the population of leucylated tRNA in the reaction tube, thus increasing 
the concentration of deacylated tRNA. Therefore, the equilibrium of the leucylation reaction 
is skewed toward the deacylated product, which can be seen in figure 3A as both mutants fail 
to reach the maximal reaction velocity of wild type LeuRS. 
 
We have hypothesized that FN1 and D391A affect the pre-aminoacylation translocation step, 
but we also believe these mutants may affect the post-aminoacylation translocation step. Our 
biochemical data supports this finding. In figure 3B, the rates of hydrolysis for both mutants 
are reduced, which we hypothesize is the result of a defunct translocation pathway into the 
editing active site. The hydrolysis activity that was observed is mainly attributed to the direct 
binding of the mischarged tRNA into the editing active site without undergoing translocation. 
We have hypothesized that the hydrolysis reaction encompasses non-enzymatic hydrolysis, 
hydrolysis via direct binding to the editing active site and hydrolysis through a translocation 
pathway that originates at the leucylation active site and ends at the editing active site. If all 
modes of editing were occurring we would see the rapid hydrolysis of misacylated tRNA 
until equilibrium was reached, as is the case with wild type LeuRS. However, for FN1 and 
D391A we see a reduced rate of hydrolysis as well as a failure to reach equilibrium. We 
believe that this result stems from a lack of translocation of tRNA between the two active 
sites, therefore the only operating modes of hydrolysis are non-enzymatic and the direct 
binding of tRNA to the CP1 domain.  
 
Additionally, this finding is supported by the misaminoacylation activity of both FN1 and 
D391A. We have shown (Figure 3C) that these mutants produce approximately 2-5 
picomoles of Ile-tRNALeu in a 90 minute reaction. This product is less than half of the Leu-
tRNALeu product that is generated by these mutants in a 15 minute reaction. Though these 
mutants do not have robust mischarging rates, we believe that this finding is significant. We 
attribute the formation of aberrant product to the lack of movement of tRNA into the CP1 
domain from the aminoacylation active site. Just like with previous biochemical findings, we 
feel that the initial rates of translocation into the active site are reduced, thus dropping the 
overall production of product. Once mischarged product is generated, it is released from the 
enzyme without undergoing translocation, which allows mischarged product to be detected. 
Non-enzymatic deacylation and deacylation via direct binding to the CP1 domain also occur, 
which further reduces the concentration of mischarged tRNA product. 
 
From these in vitro studies, we have advocated that our mutants have defunct translocation 
pathways for both the pre-aminoacylation and post-aminoacylation translocation events. We 
have also supported our findings with in vivo experiments which demonstrate that FN1 and 
D391A are non-functional in E. coli cells. We hypothesize that these mutants reduce the rates 
of the canonical biochemical reactions of LeuRS and thus render the mutant enzymes unable 
to produce sufficient product to meet the synthesis demands of the bacterial cell. When 
expressed in bacterial cells, these mutant enzymes may result in a reduced occurrence of 
ribosomal leucine incorporation during translocation. 
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In conclusion, we hypothesize that these mutations have not significantly altered the structure 
of LeuRS. We further believe that these mutations do not directly alter the functionality of the 
active sites. Based on our data, we believe that these residues in the wild type enzyme may 
help promote the conformational changes that the translocation peptide may undergo 
throughout LeuRS’s reaction cycle. Therefore, FN1 and D391A may reduce the rates of 
translocation, which impairs the biochemical processes of LeuRS that ultimately leads to 
bacterial death. 
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